Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.

作者: J Behr , C Vogelmeier , T Beinert , M Meurer , F Krombach

DOI: 10.1164/AJRCCM.154.2.8756813

关键词:

摘要: Fibrosing alveolitis (FA) is a frequent and often fatal complication of systemic sclerosis (SSC). Alveolar inflammation has been recognized as primary event in the pulmonary manifestation SSC. To evaluate significance SSC, we performed bronchoalveolar lavage (BAL) correlated generated data with changes lung function over time. Seventy nine SSC patients involvement were followed for 56.8 +/- 3.1 wk (mean SEM) repeat test at end follow-up period. During follow-up, 38 treated immunosuppressive regimen. For evaluation, assigned to two groups according whether their BAL cell differential was normal (inactive BAL) or abnormal (active BAL: i.e., polymorphonuclear leukocytes > 5% and/or lymphocytes 15%). Active associated more severe impairment than inactive BAL, active deteriorated during if untreated. In contrast, stabilized improved. summary, characterized by progressive disease patients, significant positive effect therapy on course observed BAL.

参考文章(20)
Bruce Thiers, Connective tissue disease Journal of the American Academy of Dermatology. ,vol. 2, pp. 263- 267 ,(1980) , 10.1016/S0190-9622(80)80017-X
V J Ferrans, R G Crystal, O Kawanami, G W Hunninghake, J E Gadek, Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. American Journal of Pathology. ,vol. 97, pp. 149- 206 ,(1979)
William A. D'Angelo, James F. Fries, Alfonse T. Masi., Lawrence E. Shulman, Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls The American Journal of Medicine. ,vol. 46, pp. 428- 440 ,(1969) , 10.1016/0002-9343(69)90044-8
Gerhard König, Christoph Luderschmidt, Claus Hammer, Bernhard C. Adelmann-Grill, Otto Braun-Falco, Günter Fruhmann, Lung Involvement in Scleroderma Chest. ,vol. 85, pp. 318- 324 ,(1984) , 10.1378/CHEST.85.3.318
Giovanni A. Rossi, Peter B. Bitterman, Stephen I. Rennard, Victor J. Ferrans, Ronald G. Crystal, Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. The American review of respiratory disease. ,vol. 131, pp. 612- 617 ,(1985) , 10.1164/ARRD.1985.131.4.612
Virginia D. Steen, Gregory R. Owens, Carol Redmond, Thomas A. Medsger, The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis & Rheumatism. ,vol. 28, pp. 882- 888 ,(1985) , 10.1002/ART.1780280807
Anita Åkesson, Agneta Scheja, Anders Lundin, Frank A. Wollheim, Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide Arthritis & Rheumatism. ,vol. 37, pp. 729- 735 ,(1994) , 10.1002/ART.1780370518
Peter Libby, Gary B. Friedman, Robert N. Salomon, Cytokines as Modulators of Cell Proliferation in Fibrotic Diseases American Review of Respiratory Disease. ,vol. 140, pp. 1114- 1117 ,(1989) , 10.1164/AJRCCM/140.4.1114
M. Meurer, N. Hunzelmann, J. Behr, R. Hein, M. Hündgen, T. Krieg, O. Braun‐Falco, A. Urbanski, Treatment of systemic sclerosis with γ-interferon British Journal of Dermatology. ,vol. 126, pp. 496- 501 ,(1992) , 10.1111/J.1365-2133.1992.TB15122.X
David A. Johnson, Pulmonary Disease in Progressive Systemic Sclerosis Archives of Internal Medicine. ,vol. 149, pp. 589- 593 ,(1989) , 10.1001/ARCHINTE.1989.00390030075014